Replies to post #393398 on Innovation Pharmaceuticals Inc (IPIX)

[Lemoncat]

Brilacidin is now in a nasal administered anti-viral

Ah so that's the new 2022 Brilacidin indication? It's like we get a new one each year that we can't monetize. I was afraid we wouldn't get a new one this year.

Flucide 2.0.

Go Innoviricides!

[sunspotter]

Brilacidin is now in a nasal administered anti-viral going through dose strategy testing in-vivo.

There is literally no evidence to suggest that any nasal formulation of brilacidin is being tested in vivo, but the absence of such evidence, given the CEO's propensity to PR the smallest positive item (while neglecting to comply with the Securities Act or informing the market of material events in a timely manner) and the fact that no trials have been registered for this alleged formulation at clinicaltrials.gov suggests that it is not true.